Dr. Reddy's Laboratories
RDY
#1699
Rank
S$15.38 B
Marketcap
S$18.39
Share price
0.35%
Change (1 day)
-5.13%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): S$1.20 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are S$3.95 Billion. In 2024 the company made an earning of S$1.16 Billion, an increase over its 2023 earnings that were of S$1.08 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$1.20 B3.97%
2024 S$1.16 B7.01%
2023 S$1.08 B17.62%
2022 S$0.92 B43.27%
2021 S$0.64 B31.44%
2020 S$0.49 B54.54%
2019 S$0.31 B-14.21%
2018 S$0.37 B26.15%
2017 S$0.29 B4.69%
2016 S$0.28 B-55.7%
2015 S$0.63 B1.83%
2014 S$0.62 B-3.78%
2013 S$0.64 B54.07%
2012 S$0.41 B-16.23%
2011 S$0.50 B56.66%
2010 S$0.31 B-235.36%
2009 -S$0.24 Billion-198.53%
2008 S$0.23 B30.77%
2007 S$0.18 B-14.61%
2006 S$0.21 B703.63%
2005 S$26.69 M649.45%
2004 S$3.56 M-95.68%
2003 S$82.36 M-14.86%
2002 S$96.73 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.35 B 1,189.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.29 B 92.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$12.08 B 914.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
S$21.27 B 1,686.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$11.79 B 890.26%๐Ÿ‡ซ๐Ÿ‡ท France